Zurcher Kantonalbank (Zurich Cantonalbank) Atri Cure, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $33.8 Billion
- Q1 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Atri Cure, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 14,435 shares of ATRC stock, worth $541,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,435
Previous 13,058
10.55%
Holding current value
$541,889
Previous $399,000
16.54%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ATRC
# of Institutions
233Shares Held
51.4MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$177 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$173 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$138 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$113 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$91.5 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.74B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...